SEC.gov | Becton Dickinson to Pay $175 Million for Misleading …

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

$175
OFF

SEC.gov | Becton Dickinson To Pay $175 Million For Misleading …

3 weeks from now

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

sec.gov

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024 · Dive Brief: BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with …

medtechdive.com

$175
OFF

Becton, Dickinson To Pay $175M To Settle Claims Over Misleading …

3 weeks from now

The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued …

msn.com

$175
OFF

BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System ...

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris …

businessinsider.com

$175
OFF

BD Pays $175M To Settle SEC Claims It Failed To Report Infusion …

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission (SEC) today announced settled charges against Becton, Dickinson and Company (BD), a New Jersey-based medical device …

medicaldesigndevelopment.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors

3 weeks from now

Dec 16, 2024 · Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and …

nasdaq.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 17, 2024 · * New Jersey-based company will also retain independent compliance consultant. Washington D.C. - The Securities and Exchange Commission today announced settled …

marketscreener.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors On …

3 weeks from now

Dec 20, 2024 - Compliance & Ethics - Becton, Dickinson and Company (BD), a New Jersey-based medical device manufacturer, has agreed to pay a $175 million civil penalty to the …

grcreport.com

$175
OFF

Becton Dickinson Settles Charges Over Infusion Pump Risks, SEC …

3 weeks from now

The SEC said Becton Dickinson agreed to pay a $175 million civil penalty to settle the charges, which also allege that the company overstated its income by failing to disclose the costs of ...

msn.com

$85
OFF

Becton Dickinson To Pay $85 Million To Resolve Claims Over Alaris ...

3 weeks from now

Dec 21, 2023 · Investors accused the company of hiding looming regulatory hurdles impacting sales of its Alaris infusion pump. Becton Dickinson and its management have denied any …

morningstar.com

FAQs about SEC.gov | Becton Dickinson to Pay $175 Million for Misleading … Coupon?

Did Becton Dickinson mislead investors about Alaris?

The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD) over allegations it misled investors about risks associated with its Alaris infusion pump. ...

Why did Becton Dickinson pay a $175 million civil penalty?

The SEC said Becton Dickinson agreed to pay a $175 million civil penalty to settle the charges, which also allege that the company overstated its income by failing to disclose the costs of software repairs associated with the pump. (Reporting by Caitlin Webber) ...

Did Becton Dickinson pay a $85 million settlement?

Becton Dickinson agreed to pay a settlement of $85 million to resolve claims against the company and its officers regarding the Alaris infusion pump. The medical technology company filed the settlement documents and is seeking approval by the U.S. District Court for the District of New Jersey. ...

Why did the SEC settle charges against BD?

The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. ...

Why did Becton Dickinson acquire CareFusion?

Becton Dickinson acquired CareFusion in 2015. The operations of CareFusion have been merged into those of Becton Dickinson, greatly increasing the Company’s capabilities and broadening the Company’s product range. ...

Did Becton Dickinson hide looming regulatory hurdles affecting sales?

Investors accused Becton Dickinson of concealing looming regulatory hurdles impacting sales of its Alaris infusion pump. Becton Dickinson and its management have denied any wrongdoing. (END) Dow Jones Newswires December 21, 2023 17:35 ET (22:35 GMT) ...